Novel Markers for Improved Diagnosis of Rheumatoid Arthritis
The combined use of RFs with the anti-cyclic citrullinated peptide (anti-CCP) or assays resulted in detection levels of about 40% of early arthritis patients and 70-80% of established RA patients.
Weitere Informationen: PDF
ipal GmbH
Tel.: +49 (0)30/2125-4820
Ansprechpartner
Ursula Haufe
